GHK-Cu

Research OnlyModerate Evidence
Written by dr-sarah-chen|Reviewed by Healthier Rx Editorial Board|Updated 2026-04-01|4 min read
Quick Facts
TypeAnti-Aging
FDA StatusResearch Only
Evidence LevelModerate Evidence
Typical Dose1-2mg
FrequencyDaily or every other day
Cycle Length4-8 weeks
Key GoalsAnti-Aging, Skin Health, Injury Recovery

How It Works

GHK-Cu (Glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex first identified in human plasma in 1973 by Dr. Loren Pickart. It is present in plasma, saliva, and urine, with plasma concentrations declining from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60.

The peptide functions primarily through copper delivery and gene expression modulation. GHK-Cu stimulates collagen I and III synthesis, promotes glycosaminoglycan production, and activates metalloproteinases involved in tissue remodeling. Gene array studies have shown it modulates expression of over 4,000 human genes — upregulating genes associated with tissue repair and stem cell function while suppressing genes linked to inflammation and tissue destruction.

GHK-Cu also enhances angiogenesis, promotes nerve outgrowth, and has demonstrated antioxidant activity through superoxide dismutase induction. These combined mechanisms make it relevant for anti-aging, wound healing, and tissue regeneration applications.

Benefits

  • Stimulates collagen and elastin synthesis — improved skin firmness and reduced wrinkles
  • Accelerates wound healing and tissue repair in multiple study models
  • Modulates over 4,000 genes — broad tissue remodeling and anti-inflammatory effects
  • Promotes hair growth — thickening of hair follicles in topical studies
  • Antioxidant activity — increases superoxide dismutase and other protective enzymes
  • Supports bone and cartilage repair in preclinical research

Side Effects

  • Very well-tolerated as a naturally occurring human peptide
  • Injection site reactions — redness, swelling at injection site (common)
  • Skin irritation — mild, with topical use in sensitive individuals
  • Metallic taste — occasionally reported with injectable use
  • Blue-green discoloration at injection site — due to copper content (transient)
  • No systemic toxicity reported in published literature

Dosing Protocol

ParameterDetails
Standard Dose (Injectable)1-2mg per injection
FrequencyDaily or every other day
AdministrationSubcutaneous injection or topical application
Cycle Length4-8 weeks
Topical Use1-2% cream applied once or twice daily

What You Will Need

  • GHK-Cu lyophilized vial (typically 50mg) or topical cream/serum
  • Bacteriostatic water (for reconstitution of injectable)
  • Insulin syringes (1mL, 29-31ga)
  • Alcohol swabs
  • Sharps container

Frequently Asked Questions

References

  1. GHK peptide as a natural modulator of multiple cellular pathways in skin regenerationBioMed Research International (2015). PMID: 25985606

    Comprehensive review of GHK-Cu's role in skin regeneration, collagen synthesis, and gene expression modulation.

  2. Tripeptide GHK-Cu and wound healingArchives of Dermatological Research (1999). PMID: 10195396

    Early evidence demonstrating GHK-Cu's ability to stimulate wound contraction, collagen synthesis, and angiogenesis.

  3. GHK-copper peptide modulation of gene expression: gene-to-tissue analysis of human fibroblastsGene Expression (2014). PMID: 24960295

    Gene array analysis showing GHK-Cu modulates expression of over 4,000 genes, many involved in tissue remodeling and anti-inflammatory processes.

Compare GHK-Cu

Protocols Featuring GHK-Cu

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new treatment or protocol. Read our full medical disclaimer.